Found: 51
Select item for more details and to access through your institution.
Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 690, doi. 10.1007/s10637-019-00816-1
- By:
- Publication type:
- Article
Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients.
- Published in:
- Rheumatology, 2011, v. 50, n. 2, p. 417, doi. 10.1093/rheumatology/keq218
- By:
- Publication type:
- Article
Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 196, doi. 10.3390/vaccines10020196
- By:
- Publication type:
- Article
Fortification of blood plasma from cancer patients with human serum albumin decreases the concentration of cisplatin-derived toxic hydrolysis products in vitro.
- Published in:
- Metallomics, 2014, v. 6, n. 11, p. 2034, doi. 10.1039/c4mt00220b
- By:
- Publication type:
- Article
Chemoprotection by d-methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma.
- Published in:
- Metallomics, 2014, v. 6, n. 3, p. 532, doi. 10.1039/c3mt00238a
- By:
- Publication type:
- Article
Survivin as a Preferential Target for Cancer Therapy.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 2, p. 2494, doi. 10.3390/ijms15022494
- By:
- Publication type:
- Article
Current advances in immunotherapy for atypical teratoid rhabdoid tumor (ATRT).
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 4, p. 322, doi. 10.1093/nop/npad005
- By:
- Publication type:
- Article
Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The Small-Molecule E26-Transformation-Specific Inhibitor TK216 Attenuates the Oncogenic Properties of Pediatric Leukemia.
- Published in:
- Genes, 2023, v. 14, n. 10, p. 1916, doi. 10.3390/genes14101916
- By:
- Publication type:
- Article
The Developmental Origins of Cancer: A Review of the Genes Expressed in Embryonic Cells with Implications for Tumorigenesis.
- Published in:
- Genes, 2023, v. 14, n. 3, p. 604, doi. 10.3390/genes14030604
- By:
- Publication type:
- Article
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 346, doi. 10.3390/curroncol28010038
- By:
- Publication type:
- Article
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML.
- Published in:
- Clinical Epigenetics, 2017, v. 9, p. 1, doi. 10.1186/s13148-017-0411-x
- By:
- Publication type:
- Article
Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors.
- Published in:
- Molecular Oncology, 2013, v. 7, n. 5, p. 944, doi. 10.1016/j.molonc.2013.05.004
- By:
- Publication type:
- Article
Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR- ErbB2 signaling with lapatinib.
- Published in:
- Molecular Oncology, 2013, v. 7, n. 3, p. 497, doi. 10.1016/j.molonc.2013.01.001
- By:
- Publication type:
- Article
Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 4, p. 397, doi. 10.1038/sj.cgt.7700798
- By:
- Publication type:
- Article
Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1461, doi. 10.1007/s00432-019-02913-3
- By:
- Publication type:
- Article
Aurora Kinases as Druggable Targets in Pediatric Leukemia: Heterogeneity in Target Modulation Activities and Cytotoxicity by Diverse Novel Therapeutic Agents.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0102741
- By:
- Publication type:
- Article
Polo-Like Kinase 1 Inhibition Kills Glioblastoma Multiforme Brain Tumor Cells in Part Through Loss of SOX2 and Delays Tumor Progression in Mice.
- Published in:
- Stem Cells, 2012, v. 30, n. 6, p. 1064, doi. 10.1002/stem.1081
- By:
- Publication type:
- Article
Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 230, doi. 10.1002/pbc.24278
- By:
- Publication type:
- Article
Phase I dose-escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 7, p. 1252, doi. 10.1002/pbc.24264
- By:
- Publication type:
- Article
MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL).
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 4, p. 599, doi. 10.1002/pbc.24167
- By:
- Publication type:
- Article
Effects of Hsp90 inhibition in neuroblastoma: Analysis of drug sensitivity, target modulation and the influence of bone marrow microenvironment.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2008, v. 7, n. 3, p. 183
- By:
- Publication type:
- Article
Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement.
- Published in:
- Pediatric Blood & Cancer, 2011, v. 56, n. 3, p. 353, doi. 10.1002/pbc.22760
- By:
- Publication type:
- Article
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): Review from an international consensus conference.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 54, n. 7, p. 872, doi. 10.1002/pbc.22414
- By:
- Publication type:
- Article
Differentiation of rhabdomyosarcoma cell lines using retinoic acid.
- Published in:
- Pediatric Blood & Cancer, 2006, v. 47, n. 6, p. 773, doi. 10.1002/pbc.20650
- By:
- Publication type:
- Article
Curcumin Blocks Kv11.1 (erg) Potassium Current and Slows Proliferation in the Infant Acute Monocytic Leukemia Cell line THP-1.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2011, v. 28, n. 6, p. 1169, doi. 10.1159/000335850
- By:
- Publication type:
- Article
Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy.
- Published in:
- Biomedicines, 2024, v. 12, n. 3, p. 503, doi. 10.3390/biomedicines12030503
- By:
- Publication type:
- Article
Development and validation of a 21-gene prognostic signature in neuroblastoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37714-9
- By:
- Publication type:
- Article
Identification and In Vivo Validation of Unique Anti-Oncogenic Mechanisms Involving Protein Kinase Signaling and Autophagy Mediated by the Investigational Agent PV-10.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1520, doi. 10.3390/cancers16081520
- By:
- Publication type:
- Article
Identification of Altered Primary Immunodeficiency-Associated Genes and Their Implications in Pediatric Cancers.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5942, doi. 10.3390/cancers14235942
- By:
- Publication type:
- Article
Cannabinol Inhibits Cellular Proliferation, Invasion, and Angiogenesis of Neuroblastoma via Novel miR-34a/tRiMetF31/PFKFB3 Axis.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1908, doi. 10.3390/cancers14081908
- By:
- Publication type:
- Article
Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 126, n. 1, p. 73, doi. 10.1007/s10549-010-0889-9
- By:
- Publication type:
- Article
Potent in vitro and xenograft antitumor activity of a novel agent, PV-10, against relapsed and refractory neuroblastoma.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 1293, doi. 10.2147/OTT.S191478
- By:
- Publication type:
- Article
The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 2581, doi. 10.2147/OTT.S136484
- By:
- Publication type:
- Article
Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2015, v. 34, n. 1, p. 1, doi. 10.1186/s13046-015-0222-x
- By:
- Publication type:
- Article
Mechanisms of defective erythropoiesis and anemia in pediatric acute lymphoblastic leukemia (ALL).
- Published in:
- Annals of Hematology, 2012, v. 91, n. 10, p. 1513, doi. 10.1007/s00277-012-1475-5
- By:
- Publication type:
- Article
Ion channels in pediatric CNS Atypical Teratoid/Rhabdoid Tumor (AT/RT) cells: potential targets for novel therapeutic agents.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 107, n. 1, p. 111, doi. 10.1007/s11060-011-0735-x
- By:
- Publication type:
- Article
Establishment of atypical-teratoid/rhabdoid tumor (AT/RT) cell cultures from disseminated CSF cells: a model to elucidate biology and potential targeted therapeutics.
- Published in:
- Journal of Neuro-Oncology, 2008, v. 90, n. 2, p. 171, doi. 10.1007/s11060-008-9653-y
- By:
- Publication type:
- Article
Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia.
- Published in:
- Oncology Letters, 2017, v. 13, n. 1, p. 497, doi. 10.3892/ol.2016.5437
- By:
- Publication type:
- Article
ATRT-15. TARGETING LIN28 REGULATED PATHWAYS IN NOVEL THERAPEUTICS DEVELOPMENT FOR CNS ATYPICAL TERATOID/RHABDOID TUMOR (CNS ATRT).
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii66, doi. 10.1093/neuonc/noz036.013
- By:
- Publication type:
- Article
Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 1, p. 142, doi. 10.1093/neuonc/nov271
- By:
- Publication type:
- Article
Response to “Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?”.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 1, p. 143, doi. 10.1093/neuonc/nov290
- By:
- Publication type:
- Article
In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 8, p. 1086, doi. 10.1093/neuonc/nou359
- By:
- Publication type:
- Article
Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 6, p. 822, doi. 10.1093/neuonc/nou310
- By:
- Publication type:
- Article
A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 1, p. 62, doi. 10.1093/neuonc/not162
- By:
- Publication type:
- Article
Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy.
- Published in:
- Metallomics, 2016, v. 8, n. 11, p. 1170, doi. 10.1039/c6mt00183a
- By:
- Publication type:
- Article
Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib.
- Published in:
- 2018
- By:
- Publication type:
- journal article